India, Nov. 4 -- The Government of India has issued a release:
In a significant step towards strengthening the regulatory framework for ensuring the quality and safety of medicines in the country, the Union Ministry of Health and Family Welfare has proposed amendments to the Drugs Rules, 1945, to provide for immediate suspension of manufacturing licences in respect of drugs declared Not of Standard Quality (NSQ) on specified critical quality parameters.
The proposed amendments seek to enable prompt regulatory intervention upon detection of substandard medicines, prevent their continued manufacture and distribution, and strengthen the mechanism for ensuring compliance with prescribed quality standards, in the interest of patient safety and...